| Mepha Pharma AG - Rivaroxaban-Mepha Teva 15mg, Filmtabletten | | 68439 | | 02 | | Rivaroxaban-Mepha Teva 15mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 15.03.2022 | | |
| | Composition | | rivaroxabanum 15 mg, natrii laurilsulfas, lactosum monohydricum 125.4 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.89 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 15 mg |
| | BAG: Active Agent | Dose |
|---|
| Rivaroxabanum | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 125.4 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 017 | 14 | | | B | | Yes | | 018 | 28 | | | B | | Yes | | 019 | 98 | | | B | | Yes | | 020 | 100 | | | B | | Yes |
|
|
